Experience

Immuto Scientific

• United States
• Biotechnology Research
• 1 - 100 Employee

• Scientific Director

  • May 2022 - Present

  -Lead research and development efforts -Develop business strategies for drug discovery services -Interface with clients on project design and execution -Train and mentor junior staff -Lead research and development efforts -Develop business strategies for drug discovery services -Interface with clients on project design and execution -Train and mentor junior staff



Arrowhead Pharmaceuticals

• United States
• Pharmaceutical Manufacturing
• 200 - 300 Employee

• Senior Scientist II

  • Nov 2021 - May 2022

  -Managed multiple projects in preclinical DMPK to support drug candidate selection program -Performed pharmacokinetic analysis of siRNA-based drug candidates via mass spectrometry -Acted as subject matter liaison between discovery chemistry and CNS biology teams -Managed multiple projects in preclinical DMPK to support drug candidate selection program -Performed pharmacokinetic analysis of siRNA-based drug candidates via mass spectrometry -Acted as subject matter liaison between discovery chemistry and CNS biology teams



Wisconsin Institute for Discovery

• United States
• Research
• 1 - 100 Employee

• Research Scientist

  • Sep 2012 - Oct 2021

  -Managed mass spectrometry core and associated collaborations within Epigenetics Theme -Trained and mentored over a dozen graduate students in proteomics, metabolomics, and molecular biology -Authored and co-authored NIH grants -Developed and implemented novel mass spectrometry methods for the analysis of epigenetic alterations in Alzheimer's disease -Managed mass spectrometry core and associated collaborations within Epigenetics Theme -Trained and mentored over a dozen graduate students in proteomics, metabolomics, and molecular biology -Authored and co-authored NIH grants -Developed and implemented novel mass spectrometry methods for the analysis of epigenetic alterations in Alzheimer's disease



Waisman Center

• United States
• Research Services
• 1 - 100 Employee

• Research Scientist

  • Sep 2011 - Aug 2012

  -Validated proteomics-identified targets via molecular biological techniques -Mentored junior staff members -Identified targets of c-Jun terminal kinase and their role in Fragile X syndrome via quantitative proteomics -Validated proteomics-identified targets via molecular biological techniques -Mentored junior staff members -Identified targets of c-Jun terminal kinase and their role in Fragile X syndrome via quantitative proteomics



University of Wisconsin

• Higher Education
• 700 & Above Employee

• Post-Doctoral Fellow

  • Sep 2008 - Sep 2011

  -Identified key neuroprotective enzymes via quantitative proteomics, bioinformatics, molecular biology, and enzymatic assays -Trained graduate students in cell culturing and molecular biology techniques -Wrote independent grant proposals and original scientific manuscripts

• Doctoral Researcher

  • Aug 2003 - Aug 2008

  -Developed novel mass spectrometry methods for the analysis of mammalian neuropeptides -Taught laboratory classes in drug delivery and pharmaceutical biochemistry



ICOS Corporation

• United States
• Pharmaceutical Manufacturing

• Quality Control Associate

  • Aug 2000 - Jul 2003

  -Developed analytical methods for the analysis of small molecule and protein drugs in a GMP environment -Directed junior scientists in the testing of small molecules and biopharmaceuticals -Developed analytical methods for the analysis of small molecule and protein drugs in a GMP environment -Directed junior scientists in the testing of small molecules and biopharmaceuticals